$72.85
$0.00 (0.00%)
End-of-day quote: 05/03/2024
NYSE:BSX

Boston Scientific Annual Report

Year Year 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Rev. Revenue
$14.24B $12.68B $11.89B $9.91B $10.74B $9.82B $9.05B $8.39B $7.48B $7.31B $7.07B $7.25B $7.62B $7.81B $8.19B $8.05B $8.36B $7.82B $6.28B $5.62B
GM % Gross Margin %
69.16% 68.44% 68.37% 68.53% 71.09% 71.19% 71.20% 70.82% 70.90% 69.68% 68.30% 65.60% 63.33% 64.95% 66.82% 67.02% 69.58% 71.93% 74.09% 73.38%
OM Operating Margin
16.97% 16.03% 15.34% 11.39% 17.06% 17.55% 17.67% 16.59% 14.48% 13.12% 12.83% 13.17% 13.49% 13.36% 15.96% 16.09% 14.37% 19.09% 32.21% 30.48%
EPS Earnings Per Share
$0.00 $2.05 $1.71 $1.63 $0.96 $1.58 $1.47 $1.26 $1.11 $0.93 $0.84 $0.46 $0.41 $0.45 $0.42 $0.50 $0.81 $0.77 $1.14 $1.82 $1.63
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Sha. Shares
1465.71m 1433.34m 1425.52m 1416.62m 1394.92m 1384.58m 1373.5m 1362.1m 1346.65m 1327.45m 1322.3m 1355.71m 1449.06m 1520.78m 1510.75m 1501.64m 1491.23m 1474.67m 820.35m 835.34m
OCF Operating Cash Flow
$2.50B $1.53B $1.87B $1.51B $1.84B $310.00M $1.43B $1.18B $691.00M $1.27B $1.11B $1.28B $1.01B $325.00M $835.00M $1.22B $934.00M $1.85B $903.00M $1.80B
FCF Free Cash Flow
$2.06B $938.00M $1.32B $1.13B $1.38B $-6.00M $1.73B $1.61B $353.00M $1.01B $837.00M $1.03B $720.00M $53.00M $523.00M $854.00M $571.00M $1.50B $562.00M $1.53B
FCFS Free Cash Flow Per Share
$1.23 $0.67 $0.94 $0.84 $1.03 $-0.00 $0.81 $0.59 $0.33 $0.76 $0.64 $0.75 $0.47 $0.03 $0.35 $0.57 $0.38 $1.18 $0.68 $1.83